Compare AMBA & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMBA | PAHC |
|---|---|---|
| Founded | 2004 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2011 | 2014 |
| Metric | AMBA | PAHC |
|---|---|---|
| Price | $50.42 | $53.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $97.25 | $34.33 |
| AVG Volume (30 Days) | ★ 911.2K | 258.4K |
| Earning Date | 02-26-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.86% |
| EPS Growth | 37.32 | ★ 1883.33 |
| EPS | N/A | ★ 1.32 |
| Revenue | $295,402,000.00 | ★ $833,350,000.00 |
| Revenue This Year | $15.69 | $17.03 |
| Revenue Next Year | $13.06 | $3.82 |
| P/E Ratio | ★ N/A | $42.28 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $38.90 | $16.16 |
| 52 Week High | $96.69 | $57.62 |
| Indicator | AMBA | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 31.98 | 55.44 |
| Support Level | N/A | $37.09 |
| Resistance Level | $71.00 | $56.14 |
| Average True Range (ATR) | 2.15 | 2.43 |
| MACD | 0.17 | 0.22 |
| Stochastic Oscillator | 7.16 | 57.90 |
Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.